Compare Immunovant Inc. Common Stock (IMVT) vs SanDisk (SNDK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs SanDisk — how do they compare? Immunovant Inc. Common Stock trades at $30.18 (market cap $6.25B), while SanDisk trades at $1,597.01 (market cap $232.61B). The key difference: SanDisk is far larger — about 37.2× Immunovant Inc. Common Stock's market cap, and SanDisk is more actively traded (9,218,054 versus 1,755,411). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and SanDisk for 8 Days on average.
| IMVT | SNDK | |
|---|---|---|
Market Cap | $6.25B | $232.61B |
Volume | 1,755,411 | 9,218,054 |
Sector | Health | Technology |
52-Week High | $44.96 | $2.34K |
52-Week Low | $17.03 | $116.91 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $5.35B | $228.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About SanDisk
Sandisk is a semiconductor memory company specializing in NAND flash technology. Its storage products support consumer devices, enterprise systems, and cloud and AI infrastructure.
Read more on SNDK →
